Diabetic Kidney Disease in Childhood and Adolescence: Conventional and Novel Renoprotective Strategies

  • Uwaezuoke S
  • Ayuk A
N/ACitations
Citations of this article
14Readers
Mendeley users who have this article in their library.

Abstract

Diabetic kidney disease (DKD) is defined as a clinical syndrome consisting of persistent macroalbuminuria, progressive decline in glomerular filtration rate (GFR), hypertension, increased cardiovascular disease events, and the associated mortality of these conditions. The disease evolves from the microvascular complications of poorly controlled Type 1 diabetes mellitus (T1DM) and Type 2 diabetes mellitus (T2DM). The pathogenic pathways comprise renal haemodynamic changes, ischaemia and inflammation, and overactive renin–angiotensin–aldosterone system (RAAS), through which several events cascade down from hyperglycaemia to renal fibrosis. Conventional and novel renoprotective strategies target modifiable DKD risk factors and specific stages of the pathogenic pathways, respectively. Although these strategies may slow DKD progression to end-stage kidney disease (ESKD), novel drugs are still undergoing trials for validation in human participants. This narrative review appraises these renoprotective strategies and highlights the current clinical staging and pathogenesis of the disease.

Cite

CITATION STYLE

APA

Uwaezuoke, S. N., & Ayuk, A. C. (2020). Diabetic Kidney Disease in Childhood and Adolescence: Conventional and Novel Renoprotective Strategies. EMJ Nephrology, 68–77. https://doi.org/10.33590/emjnephrol/20-00077

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free